Moody’s Analytics Launches New Model of the Global Economy and Collaborative Forecasting Platform
Moody’s Analytics, a leading financial intelligence firm, is pleased to announce the launch of its new Global Macroeconomic Model. The model forecasts more than 10,000 globally inter-linked economic and financial time series that collectively account for 95% of global economic activity. The model is delivered through the Scenario Studio web-based platform, a Moody’s Analytics innovation that enables real-time interactive collaboration on economic scenarios or forecasts among multiple concurrent users.
Financial institutions, governments, and corporate clients can use the Global Macroeconomic Model to determine the impact of domestic and foreign economic shocks. The model accounts for trade flows, financial market conditions, migration, commodity prices and foreign investment. It captures the complexity of the global economy, and demonstrates that the economic impacts of government policy changes and geopolitical events are much larger and reverberate more broadly across the globe and for longer than is commonly thought.
“The global economy continues to become more integrated through trade, migration and investment,” said Mark Zandi, Moody’s Analytics Chief Economist. “With the global business and credit cycle maturing, the Global Macroeconomic Model provides a critical tool for assessing the impact of changing economic and monetary policy and geopolitical events, and for developing scenarios of future economic conditions.”
The model and web-based platform allow users to create multiple scenarios simultaneously. Forecasts obtained through the model are fully documented and transparent, supported by rigorous governance processes that stand up to regulatory and audit scrutiny. Advanced technology in the Scenario Studio platform helps clients generate scenarios required for regulatory compliance and accounting standards such as CCAR, ICAAP, IFRS9, and CECL.
“The Global Macroeconomic Model balances economic theory and empirical analysis,” added Marisa DiNatale, Global Head of Forecasting at Moody’s Analytics. “As demands on economists and risk managers increase, their tools have to keep pace with the increasing complexity of global economics and regulatory requirements. We are pleased to bring to market a powerful tool to help clients meet that need.”
This is the same global model and platform used by the Moody’s Analytics economics forecasting team, which is recognized for its national and sub-national forecasting and scenario analyses. Our economists are using the model to produce a series of research papers that investigate the global consequences of some of today’s most pressing and difficult economic questions, such as the escalating trade tensions between the U.S. and its trading partners, the cross-border consequences of Brexit and the recent political instability in Italy, swings in energy prices, and the potential break-up of the North American Free Trade Agreement.
In a paper published today, “ In No Good Hands: The Venezuela Crisis and Consequences for South America ”, Moody’s Analytics Economists, including Marisa DiNatale, use the Global Macroeconomic Model to assess the economic consequences for Venezuela and the rest of South America if Venezuela’s President Maduro serves out his new presidential term or if he is removed from office.
Other topics that the research series will cover include:
- Risks to China’s economy and the consequences for Southeast Asia. View First Paper
- US and trade: globalization and its discontents. View First Paper
- Climate Change: preparing for the economic fallout
- (Dis)unity in Europe
- Consumers: the engine of global growth?
- The Productivity Puzzle
Visit the Moody’s Analytics “Global Economic View” microsite for our latest research on these global themes.
To learn more about the Moody’s Analytics Global Model methodology and research, join our upcoming webinar, where economists, including Mark Zandi, will describe the capabilities of the global model and forecast governance processes, and highlight scenarios based on recent Moody’s Analytics research.
About Moody’s Analytics
Moody’s Analytics provides financial intelligence and analytical tools supporting our clients’ growth, efficiency and risk management objectives. The combination of our unparalleled expertise in risk, expansive information resources, and innovative application of technology helps today’s business leaders confidently navigate an evolving marketplace. We are recognized for our industry-leading solutions, comprising research, data, software and professional services, assembled to deliver a seamless customer experience. Thousands of organizations worldwide have made us their trusted partner because of our uncompromising commitment to quality, client service, and integrity.
Moody's Analytics is a subsidiary of Moody's Corporation (NYSE: MCO). MCO reported revenue of $4.2 billion in 2017, employs approximately 11,900 people worldwide and maintains a presence in 41 countries. Further information about Moody’s Analytics is available at www.moodysanalytics.com.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia26.4.2019 11:30:00 CEST | Pressemelding
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for luspatercept for the treatment of adult patients with very low to intermediate-risk myelodysplastic syndromes (MDS)-associated anemia who have ring sideroblasts, require red blood cell (RBC) transfusions and have received or are not eligible for erythropoiesis-stimulating agents, and for the treatment of adult patients with beta-thalassemia-associated anemia who require RBC transfusions. Luspatercept is an investigational erythroid maturation agent that regulates late-stage red blood cell maturation. The safety and efficacy results provided in the application are from the pivotal phase 3 studies MEDALIST and BELIEVE, evaluating the ability of luspatercept to effectively address anemia associated with MDS and beta-thalassemia, respectively. “As a first-in-class erythroid maturation ag
SES: First Quarter 2019 Results26.4.2019 06:00:00 CEST | Pressemelding
SES S.A. announced its financial results for the three months ended 31 March 2019 with revenue and EBITDA in line with company expectations and SES on track to deliver on its 2019 financial outlook. Continued focus on execution has delivered major wins in the Networks business which is soon to be enhanced with the addition of four new O3b satellites, successfully launched at the beginning of April 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005955/en/ First Quarter 2019 Results Key financial highlights Reported revenue of EUR 480.6 million, (down 2.3% at constant FX(1)) in line with SES’ expectations Underlying revenue(2) of EUR 473.9 million; down 3.1%(1) (Video: -7.3%(1,2) and Networks +5.4%(1,2)) EBITDA of EUR 290.1 million representing a margin of 60.4% (Q1 2018: 63.7%); 62.1% excluding restructuring charge Net profit attributable to SES shareholders of EUR 72.2 million Free Cash Flow before financing acti
Wenco and Hitachi Construction Machinery Announce Open and Interoperable Partner Ecosystem for Autonomous Mining25.4.2019 23:30:00 CEST | Pressemelding
Hitachi Construction Machinery Co., Ltd. (TOKYO: 6305) (“HCM”) is pleased to announce its vision for autonomous mining — an open, interoperable ecosystem of partners that integrate their systems alongside existing mine infrastructure. Grounded in support for ISO Standards and a drive to encourage new entrants into the mining industry, HCM is pioneering this open and interoperable approach to autonomy among global mining technology leaders. With this announcement, HCM is publicly declaring support for standards-based autonomy and is offering its interoperable technology to assist mining customers in integrating new vendors into their existing infrastructure. HCM’s support for open, interoperable autonomy is based on its philosophy for its partner-focused Solution Linkage platform. “Open innovation is the guiding technological philosophy for Solution Linkage,” says Vice President and Executive Officer, Chief Technology Officer Hideshi Fukumoto. “Based on this philosophy, HCM is announcin
Garth Brooks Makes Mobile Game Debut in Words With Friends, Announces Final Pre-Order Window for The Legacy Collection25.4.2019 19:30:00 CEST | Pressemelding
Today, Zynga Inc. (Nasdaq: ZNGA), global leader in interactive entertainment, announced a collaboration with Garth Brooks, in its hit game, Words With Friends 2 . Kicking off a multi-month celebration of the game franchise’s 10th anniversary, and Brooks’ unprecedented career as a recording artist, players and fans will be treated to Garth-themed in-game activities and ongoing announcements starting with today’s reveal of ‘Journey’ as the game’s ‘Word of the Year’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005903/en/ Garth Brooks LEGACY COLLECTION (Graphic: Business Wire) Garth Brooks and Words With Friends are celebrating their 2019 milestones by giving fans new ways to interact with Garth and the game. On May 1st, Brooks will co-host Words With Friends LIVE, the nightly trivia game broadcast within Words With Friends 2. In conjunction, the FINAL pre-order window for special numbered editions of The Legacy Collect
Nordson EFD Introduces the Contact versus Jet Dispensing White Paper25.4.2019 12:16:00 CEST | Pressemelding
Nordson EFD , a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, is pleased to introduce its Contact vs. Jet Dispensing white paper. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005027/en/ As products continue to get smaller and smaller, Nordson EFD has developed new solutions to address this growing need to apply precise, repeatable micro-deposits of assembly fluids in production processes worldwide. “We understand the challenges manufacturers face when their process requires bonding tiny substrates and components together,” said Peter Langer, Business Unit Director of Valves at Nordson EFD. “The deposit tolerance requirements are considerable. And there are a number of variables to consider in order to choose the right dispensing method.” This white paper helps manufacturers understand the difference between two of the most common dispensing methods. Contact dispe
Hologic Launches Trident® HD Specimen Radiography System in United States, Canada and Europe25.4.2019 12:15:00 CEST | Pressemelding
Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005180/en/ Trident® HD Specimen Radiography System (Photo: Business Wire) The Trident products are the only specimen radiographs on the market to use amorphous selenium direct capture imaging – the same detector technology used in Hologic’s 3Dimensions™ mammography system – to generate crisp, clear, high-resolution images. The new Trident HD system, which recently received FDA clearance in the US and a CE Mark in Europe, also features a bigger detector that allows for complete imaging of larger breast surgical specimens, along with a wide range of surgical and biopsy sa